Cargando…
Targeted Molecular Construct for Bioorthogonal Theranostics of PD-L1-Expressing Cancer Cells
[Image: see text] Molecular targeting of tumor-overexpressed oncoproteins can improve the selectivity and tolerability of anticancer therapies. The immunoinhibitory membrane protein programmed death ligand 1 (PD-L1) is highly expressed on certain tumor types, which masks malignant cells from T cell...
Autores principales: | Chow, Shiao Y., Unciti-Broceta, Asier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326819/ https://www.ncbi.nlm.nih.gov/pubmed/35911461 http://dx.doi.org/10.1021/jacsau.2c00328 |
Ejemplares similares
-
Palladium-Mediated Dealkylation of N-Propargyl-Floxuridine as a Bioorthogonal Oxygen-Independent Prodrug Strategy
por: Weiss, Jason T., et al.
Publicado: (2015) -
Bioorthogonal Uncaging
of Cytotoxic Paclitaxel through
Pd Nanosheet–Hydrogel Frameworks
por: Pérez-López, Ana M., et al.
Publicado: (2020) -
Cancer-derived exosomes loaded with ultrathin palladium nanosheets for targeted bioorthogonal catalysis
por: Sancho-Albero, María, et al.
Publicado: (2019) -
In
Cellulo Bioorthogonal Catalysis
by Encapsulated AuPd Nanoalloys: Overcoming Intracellular
Deactivation
por: Rubio-Ruiz, Belén, et al.
Publicado: (2023) -
Development and Bioorthogonal Activation of Palladium-Labile
Prodrugs of Gemcitabine
por: Weiss, Jason T., et al.
Publicado: (2014)